Delivery Order SPE2DB22D1106-SPE2DB25FEQA8

Award Date 5/27/25
Potential Completion Date 5/28/25
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Boostrix TDAP vaccine syringes, with a ceiling value of $1,498.76 and a period of performance through May 14, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Boostrix TDAP vaccine syringes, with a ceiling value of $1,596.60 and a period of performance through May 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,330.50, is for the delivery of BOOSTRIX TDAP vaccine syringes (0.5ML) with a completion date of May 1, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BOOSTRIX TDAP vaccine syringes. The contract has a ceiling value of $9,579.60 and an ultimate completion date of February 25, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, a vaccine product, with a ceiling value of $28,248.90. The contract is a firm fixed-price delivery order with a performance period through May 9, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of BOOSTRIX TDAP vaccine syringes. The $1,064.40 firm-fixed-price delivery order has a completion date of June 6, 2025 and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,092,038 units of the BOOSTRIX TDAP vaccine syringe (0.5 mL). The contract has a firm fixed price of $16,764.30 and a completion date of May 1, 2025. This contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,064.40, is for the delivery of 4,568,032,429 units of the BOOSTRIX TDAP vaccine syringe (0.5 mL). The contract is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of April 28, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Boostrix TDAP vaccine syringes. The contract has a ceiling value of $56,736.69 and a completion date of June 18, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of the Boostrix TDAP vaccine syringe, 0.5 milliliters. The total ceiling value of the contract is $3,235.28, with a completion date of June 10, 2025. The contract is not set aside for any special designation. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FEQA8
    Delivery Order

This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the supply of BOOSTRIX TDAP vaccine syringes. The contract has a firm-fixed price of $1,318.30 and a completion date of May 28, 2025. It is not set aside for any specific business category. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a global pharmaceutical support vehicle through December 2026. This delivery order contract is part of the company's broader support for federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 8/31/25, 1:13 AM